News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
1don MSN
Makary repeatedly emphasized that a patient's decision to get the COVID vaccine should be made with their doctor.
In a new interview, the FDA commissioner had few answers on how Americans should think about Covid vaccines. Instead, he ...
Health on MSN3d
Why Experts Are Pushing Back on New COVID Shot Guidance for Healthy Kids, Pregnant PeopleThe HHS has removed the COVID shot from the CDC's recommended list of vaccines for these groups. Experts say they're still at ...
A new COVID-19 variant is spreading across the U.S., including in New York, raising fresh concerns just as federal vaccine ...
A new, highly transmissible COVID subvariant has been detected in California — heightening the risk of a summer wave as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback